Therefore, our findings supported the suggestions that vitamin D may be a therapeutic agent in patients with pulmonary fibrosis and lung cancer, though not only through the regulation of PSAT1 but also the SHMT1 gene. The gene discussed is PSAT1; the disease is lung carcinoma.